Difficulties in the ascertainment of C9 deficiency: Lessons to be drawn from a compound heterozygote C9-deficient subject

Clinical and Experimental Immunology

Volumn 108, Issue 3, 1997, Pages 500-506

  Hobart, M J ^a   Fernie, B A ^a   Wurzner R ^b   Oldroyd, R G ^a   Harrison, R A ^a   Joysey, V ^c   Lachmann, P J ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

alternative pathway; C9; deficiency

Indexed keywords

COMPLEMENT COMPONENT C9;

ARTICLE; BLOOD CLOTTING; CAUCASIAN; CHROMOSOME 5; CLINICAL ARTICLE; COMPLEMENT DEFICIENCY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; PRIORITY JOURNAL;

EID: 0030953145     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.3841281.x     Document Type: Article

References (40)

1. Lint TF, Howard JZ, Gewurz H. Inherited deficiency of the ninth component of complement in man. J Immunol 1980; 125:2252-7.
2. Inai S, Akagi Y. The incidence of C9 deficiency in Japan. Proceedings of the International Symposium on Frontiers of Complement Research, Kasigoshima, 1984.
3. Fukumori Y, Yoshimura K, Ohnoki S et al. A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan. Int Immunol 1989; 1:85-89.
4. Zoppi M, Weiss M, Nydegger UE et al. Recurrent meningitis in a patient with congenital deficiency of C9 component of complement. First case of C9 deficiency in Europe. Arch Intern Med 1990; 150: 2395-9.
5. Hayama K, Sugai N, Tanaka S et al. High-incidence of C9 deficiency throughout Japan: there are no significant differences in incidence among eight areas of Japan. Arch Allergy Appl Immunol 1989; 90:400-4.
6. Aγ-, δ- and β- globin genes of man. Cell 1979; 18:1-10.
7. Harrison RA, Lachmann PJ. Complement technology. In: Weir DM, ed. Handbook of experimental immunology, 4th edn. Oxford: Blackwell Scientific Publications, 1986.
8. Lachmann PJ, Thompson RA. Reactive lysis: the complement-mediated lysis of unsensitised cells. II. The characterisation of activated reactor as C56 and the participation of C8 and C9. J Exp Med 1970; 131:643-57.
9. Porath J, Axen R, Ernback S. Chemical coupling of proteins to agarose. Nature 1967; 215:1491-2.
10. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15:45-52.
11. Laurell CB. Antigen-antibody crossed electrophoresis. Anal Biochem 1965; 10:358-61.
12. Ouchterlony O, Nilsson L-A. Immunodiffusion and electrophoresis. In: Weir DM, ed. Handbook of experimental immunology, 2nd edn. Oxford: Blackwell Scientific Publications, 1973.
13. Ouchterlony O, Nilsson L-A. Immunodiffusion and electrophoresis. In: Weir DM, ed. Handbook of experimental immunology, 3rd edn. Oxford: Blackwell Scientific Publications, 1978.
14. Johansson BG. Agarose gel electrophoresis. In: Laurell CB, ed. Electrophoretic and electro-immunochemical analysis of proteins. Scand J Clin Lab Invest 1972; 29(Suppl. 124):7-19.
15. Awdeh ZL, Williamson AR, Askonas BA. Isoelectric focusing in polyacrylamide gel and its application to immunoglobulins. Nature (Lond.) 1968; 219:66-67.
16. Alper CA, Hobart MJ, Lachmann PJ. Polymorphism of the sixth component of complement. In: Arbuthnott J, Beeley J, eds. Isoelectric focusing. London: Butterworths, 1975.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Nat Acad Sci USA 1979; 76:4350-4.
19. Morgan PB, Daw RA, Siddle K et al. Immunoaffinity purification of human complement component C9 using monoclonal antibodies. J Immunol Methods 1983; 64:269-81.
20. Würzner R, Orren A, Potter P et al. Functionally active complement proteins C6 and C7 detected in C6- or C7-deficient individuals. Clin Exp Immunol 1991;83:430-7.
21. Fernie BA, Würzner R, Unsworth DJ et al. DNA polymorphisms of the complement C6 and C7 genes. Ann Hum Genet 1995; 59:163-81.
22. Fernie BA, Würzner R, Orren A, Hobart M. A new intronic polymorphism in the C7 gene 36 bp from the common expressed C7 M/N polymorphism. Ann Hum Genet 1996; 60:179-82.
23. Rogne S, Mevåg B, Gedde-Dahl T Jr, Mykelbost O. Multiple RFLPs of human complement component nine (C9) detected by TaqI. Nucl Acids Res 1990; 18:10, 3112.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. New York: Cold Spring Harbor Laboratory Press, 1989.
25. Stanley KK, Kocher H-P, Luzio JP et al. The sequence and topology of human complement component C9. EMBO J 1985; 4:375-82.
26. Marazziti D, Eggertsen G, Fey GH, Stanley KK. Relationships between gene and protein structure in human complement component C9. Biochemistry 1988; 27:6529-34.
27. Stolfi RL. Immune lytic transformation: a state of irreversible damage generated as a result of the reaction of the eighth component in the guinea pig complement system. J Immunol 1968; 100:46-54.
28. Tamura N, Shimada A, Chang S. Further evidence for immune cytolysis by antibody and the first eight components of complement in the absence of C9. Immunology 1972; 22:131-40.
29. 86Rb and hemoglobin release. J Immunol 1980, 124:1905-10.
30. Thompson RA, Lachman PJ. Reactive lysis: the complement-mediated lysis of unsensitised cells. 1. The characterisation of the indicator factor and its identification as C7. J Exp Med 1970; 131:629-41.
31. 2 by pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens. Immunochemistry 1971; 8:81-88.
32. Davies A, Wilson AB, Bramley JC et al. Identification of MIC 11 antigen as an epitope of the CD59 molecule. Immunology 1995; 85:220-7.
33. Alvarez A, Coto E, Setién F et al. Genetic detection of the silent allele (*Q0) in hereditary deficiencies of the human complement C6, C7 and C9 components. Am J Med Genetics 1995; 55:408-13.
34. Witzel K, Späth PJ, Hobart MJ et al. Genetic basis of human C9 deficiency. Mol Immunol 1996; 33(Suppl. 1):47 (Abstr.).
35. Witzel-Schlömp K, Späth P, Hobart M et al. The human complement C9 gene: identification of two mutations causing deficiency and revision of the gene structure. J Immunol 1997; in press.
36. Johnson CA, Denson P, Hurford RK et al. Type I human complement C2 deficiency: a 28 base pair deletion causes skipping of exon 6 during RNA splicing. J Biol Chem 1993; 267:9347-53, and erratum 268:2268.
37. Barba G, Rittner C, Schneider PM. Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to non-expression. J Clin Invest 1993; 91:1681-6.
38. Fernie BA, Orren A, Würzner R et al. Complement component C6 and C7 haplotypes associated with deficiencies of C6. Ann Hum Genet 1995; 59:183-95.
39. Fernie BA, Price D, Chan E et al. DNA markers in the C6 and C7 genes: biological anthopology and deficiency. Mol Immunol 1996; 33(Suppl. 1):60.
40. Nagata M, Hara T, Aoki T et al. Inherited deficiency of ninth component of complement: an increased risk of meningococcal meningitis. J Pediatr 1989; 114:260-4.